This review considers implants as modern drug delivery systems. Methods of their production by hot melt extrusion, direct pressing, and 3D printing are described. The advantages and disadvantages of implants produced by different methods are shown. The nomenclature and basic requirements for excipients necessary for effective use of the dosage forms are given. An assortment of polymers used to produce biodegradable and non-biodegradable implants is presented. Requirements for excipients for a particular method of producing a drug delivery system are described. The prospects and advantages of in situ implants as an alternative technology to produce drugs for targeted therapy are shown. Recent developments and drugs already approved for implants for ophthalmic, dental, and intranasal application and for targeted therapy of oncological diseases are reviewed.
Similar content being viewed by others
References
K. Kotova, Dental Magazine (2019); https://dentalmagazine.ru/lichnyi_opyt/istorija-odnoj-veshhi-dentalnye-implantaty.htm.
K. Warwick, M. Gasson, B. Hutt, et al., Arch. Neurol., 60(10), 1369 – 1373 (2003).
K. Battiston, I. Parrag, M. Statham, et al., Nat. Commun., 12(1), 2875 (2021).
M. Pozdneeva, Katren Style [in Russian], 203 (2020); https://www.katrenstyle.ru/goods_sales/peredovaya farmakologiya implantaty.
A. Julio, A. Sultane, A. S. Viana, et al., Pharmaceutics, 13(8), 1163 (2021).
A. Kumar and J. Pillai, “Implantable drug delivery systems: An overview,” in: Nanostructures for the Engineering of Cells, Tissues Organs, A. M. Grumezescu (ed.), Elsevier (2018), Chap. 13, pp. 473 – 511.
F. Kreye, F. Siepmann, J. F. Willart, et al., Eur. J. Pharm. Biopharm., 78, 394 – 400 (2011).
E. V. Blynskaya, S. V. Tishkov, and K. V. Alekseev, Razrab. Regist. Lek Sredstv, No. 3, 10 – 19 (2018).
I. D. Ursan, L. Chiu, and A. Pierce, J. Am. Pharm. Assoc., 53(2), 136 – 144 (2013).
W. Zhu, X. Ma, M. Gou, et al., Curr. Opin. Biotechnol., 40, 103 – 112 (2016).
S. Kotta, A. Nair, and N. Alsabeelah, Curr. Pharm. Des., 24(42), 5039 – 5048 (2018).
B. C. Gross, J. L. Erkal, S. Y. Lockwood, et al., Anal. Chem., 86(7), 3240 – 3253 (2014).
A. Fayzullin, S. Churbanov, N. Ignatieva, et al., Biomedicines, 9(8), 853 (2021).
E. O. Bakhrushina, N. B. Demina, M. M. Shumkova, et al., Razrab. Regist. Lek. Sredstv, 10(4), 54 – 63 (2021).
J. C. Quarterman, S. M. Geary, and A. K. Salem, Eur. J. Pharm. Biopharm., 159, 21 – 35 (2021).
A. A. Raheem, P. Hameed, R. Whenish, et al., Biomimetics (Basel), 6(4), 65 (2021).
B. Gupta, V. Mishra, S. Gharat, et al., Pharmaceuticals (Basel), 14(11), 1201 (2021).
T. Ferry, C. Batailler, C. Petitjean, et al., Front. Med. (Lausanne), 7, 342 (2020).
W. Xi, V. Hegde, S. D. Zoller, et al., Nat. Commun., 12, No. 1, 5473 (2021).
M. Hikal, N. Celik, G. U. Auffarth, et al., J. Clin. Med., 10, 3966 (2021).
R. Thakur and D. Jones, On Drug Delivery, 82, 28 – 31 (2018).
E. O. Bakhrushina, M. N. Anurova, N. B. Demina, et al., Razrab. Regist. Lek. Sredstv, 10(1), 57 – 66 (2021).
D. D. Kalyapin; https://cyberleninka.ru/article/n/ (accessed Dec. 28, 2021).
R. Taulu, J. Numminen, A. Bizaki, et al., Eur. Arch. Otorhinolaryngol., 272, 2335 – 2340 (2015).
T. Hickey, D. Kreutzer, D. J. Burgess, et al., Biomaterials, 23(7), 1649 – 1656 (2002).
D. W. Kennedy, Expert Rev. Respirat. Med., 6(5), 493 – 498 (2012).
A. Parikh, U. Anand, M. C. Ugwu, et al., Pharmaceutics, 6(2), 249 – 267 (2014).
A. B. W. Alecio, C. F. Ferreira, J. Babu, et al., J. Oral Implantol., 45(4), 267 – 273 (2019).
P. Wychowanski, A. Starzynska, P. Adamska, et al., Antibiotics (Basel), 10(8), 919 (2021).
Atridox (Doxycycline Hyclate); https://www.rxlist.com/atridox-drug.htm (accessed Nov. 5, 2021).
S. A. Yehia, A. Halim, and M. Y. Aziz, Curr. Drug. Delivery, 8(15), 1193 – 1203 (2018).
J. Ge, T. Liu, T. Lei, et al., Front. Pharmacol., 12, 659258 (2021).
H. Li, Z. Liu, L. Yuan, et al., Cancers (Basel), 13(21), 5459 (2021).
V. Domsta and A. Seidlitz, Molecules, 26(13), 4066 (2021).
L. Gao, S. Cai, A. Cai, et al., Drug Delivery, 26(1), 208 – 215 (2019).
L. Gao, Q. Li, J. Zhang, et al., Drug Delivery, 26(1), 1049 – 1057 (2019).
N. Yang, H. Chen, H. Han, et al., Int. J. Pharm., 552(1 – 2), 91 – 98 (2018).
Z. Jing, R. Ni, J. Wang, et al., Bioact. Mater., 6(12), 4542 – 4557 (2021).
C. Dharmayanti, T. A. Gillam, D. B. Williams, et al., Polymers (Basel), 12(12), 2930 (2020).
C. Wu, X. Yi, R. Xu, et al., Drug Delivery, 27(1), 974 – 982 (2020).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 3, pp. 42 – 49, March, 2022.
Rights and permissions
About this article
Cite this article
Bakhrushina, E.O., Demina, N.B. Implants as Targeted Drug Delivery Systems (Review). Pharm Chem J 56, 396–402 (2022). https://doi.org/10.1007/s11094-022-02649-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-022-02649-4